Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst (Nasdaq: HCAT), a leading healthcare data and analytics technology provider, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's executive team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will be present.
The company's presentation is scheduled for Wednesday, January 15, 2025, at 10:30 am PT. Investors and interested parties can access the webcast and presentation materials through Health Catalyst's investor relations website at https://ir.healthcatalyst.com.
Health Catalyst (Nasdaq: HCAT), un fornitore leader di tecnologia per dati e analisi nel settore sanitario, ha annunciato la sua partecipazione al 43° Congresso Sanitario Annuale J.P. Morgan che si svolgerà a San Francisco. Il team esecutivo dell'azienda, compresi il CEO Dan Burton, il CFO Jason Alger, il COO Dan LeSueur e il VP delle Relazioni con gli Investitori Jack Knight, sarà presente.
La presentazione dell'azienda è programmata per mercoledì 15 gennaio 2025, alle 10:30 ora del Pacifico. Gli investitori e le parti interessate possono accedere al webcast e ai materiali della presentazione attraverso il sito web delle relazioni con gli investitori di Health Catalyst all'indirizzo https://ir.healthcatalyst.com.
Health Catalyst (Nasdaq: HCAT), un proveedor líder de tecnología de datos y análisis para el sector salud, ha anunciado su participación en la 43ª Conferencia Anual de Salud J.P. Morgan en San Francisco. El equipo directivo de la empresa, incluyendo al CEO Dan Burton, al CFO Jason Alger, al COO Dan LeSueur y al VP de Relaciones con Inversores Jack Knight, estará presente.
La presentación de la empresa está programada para el miércoles 15 de enero de 2025 a las 10:30 a.m. PT. Los inversores y partes interesadas pueden acceder a la transmisión en vivo y a los materiales de la presentación a través del sitio web de relaciones con inversores de Health Catalyst en https://ir.healthcatalyst.com.
헬스 캐탈리스트(Nasdaq: HCAT)는 의료 데이터 및 분석 기술 제공업체로서 제43회 JP 모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO 댄 버튼, CFO 제이슨 알저, COO 댄 르수어, 투자자 관계 부사장 잭 나이트를 포함한 회사의 경영진이 참석할 예정입니다.
회사의 발표는 2025년 1월 15일 수요일 오전 10시 30분 PT로 예정되어 있습니다. 투자자와 이해 관계자는 헬스 캐탈리스트의 투자자 관계 웹사이트 https://ir.healthcatalyst.com를 통해 웹캐스트와 발표 자료에 접속할 수 있습니다.
Health Catalyst (Nasdaq: HCAT), un fournisseur de premier plan en technologie de données et d'analytique dans le secteur de la santé, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan sur la Santé à San Francisco. L'équipe exécutive de l'entreprise, y compris le PDG Dan Burton, le directeur financier Jason Alger, le directeur des opérations Dan LeSueur et le VP des relations avec les investisseurs Jack Knight, sera présente.
La présentation de l'entreprise est prévue pour le mercredi 15 janvier 2025 à 10h30, heure du Pacifique. Les investisseurs et les parties intéressées peuvent accéder au webinaire et aux documents de présentation via le site des relations investisseurs de Health Catalyst à l'adresse https://ir.healthcatalyst.com.
Health Catalyst (Nasdaq: HCAT), ein führender Anbieter von Gesundheitsdaten- und Analysetechnologie, hat seine Teilnahme an der 43. Jahrestagung der J.P. Morgan Healthcare Conference in San Francisco angekündigt. Das Führungsteam des Unternehmens, einschließlich CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur und VP für Investor Relations Jack Knight, wird anwesend sein.
Die Präsentation des Unternehmens ist für Mittwoch, den 15. Januar 2025 um 10:30 Uhr PT geplant. Investoren und Interessierte können über die Investor Relations-Website von Health Catalyst auf den Webcast und die Präsentationsmaterialien zugreifen unter https://ir.healthcatalyst.com.
- None.
- None.
SALT LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation on Wednesday, January 15, 2025, at 10:30 am PT. The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com.
About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
Health Catalyst Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855) 309-6800
ir@healthcatalyst.com
Health Catalyst Media Contact:
Amanda Flanders
Senior Vice President, Marketing and Communications
media@healthcatalyst.com
FAQ
When is Health Catalyst (HCAT) presenting at the J.P. Morgan Healthcare Conference 2025?
Which Health Catalyst (HCAT) executives are attending the 2025 J.P. Morgan Healthcare Conference?
Where can I access Health Catalyst's (HCAT) J.P. Morgan Healthcare Conference presentation materials?
